Patents by Inventor Michael Lobisch

Michael Lobisch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medicaments for treating dementia
    Publication number: 20040024048
    Abstract: The invention relates to the use of &agr;-lipoic acid in reduced or oxidized form or derivatives thereof with intact dithiolane structure in the form of enantiomers or pharmaceutically acceptable salts, amides, esters, thioesters, ethers or metabolites for the adjuvant therapy of dementias.
    Type: Application
    Filed: May 20, 2003
    Publication date: February 5, 2004
    Inventors: Klaus Wessel, Gerald Munch, Klaus Hager, Marlene Kenklies, Michael Lobisch, Manfred Peukert, Harald Borbe, Andreas Marahrens
  • Oral forms of administration containing solid flupirtine with controlled release of active substance
    Patent number: 6667058
    Abstract: Pharmaceutical dosage units containing flupirtine or a pharmaceutically acceptable salt of flupirtine with controlled release of active substance using a delayed-action or controlled-release component. There are 0.001 to 20 parts delayed-action component for each part by weight flupirtine (calculated as the base) and the release rate of flupirtine is between 5 and 300 mg per hour. In some cases, the dosage units may also contain a rapidly releasing component of flupirtine or of one of its salts. The dosage units reduce the sedative effect of flupirtine.
    Type: Grant
    Filed: March 17, 1994
    Date of Patent: December 23, 2003
    Assignee: Viatris GmbH & Co. KG
    Inventors: Joachim Goede, Helmut Hettche, Helmut Momberger, Jürgen Engel, Michael Lobisch
  • Treatment of migraine by administration of &agr;-lipoic acid or derivatives thereof
    Patent number: 6251935
    Abstract: The invention relates to the use of racemic &agr;-lipoic acid or its enantiomers or pharmaceutically acceptable salts, amides, esters or thioesters thereof, in reduced or oxidized form, as active ingredient in the prevention or the acute or chronic treatment of migraine.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: June 26, 2001
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Jean Schoenen, Jürgen Engel, Klaus Wessel, Manfred Peukert, Michael Lobisch, Harald Borbe
  • Combination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
    Patent number: 5521178
    Abstract: A combination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
    Type: Grant
    Filed: October 27, 1993
    Date of Patent: May 28, 1996
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Bernd Nickel, Michael Lobisch, Istvan Szelenyi, Jurgen Engel, Peter Emig, Gabriela Pergande
  • Pharmaceutical composition comprising flupirtine and its use to combat Parkinson disorders
    Patent number: 5284861
    Abstract: Flupirtine is used for the treatment of disorders involving skeletal muscle tension.
    Type: Grant
    Filed: June 1, 1992
    Date of Patent: February 8, 1994
    Assignee: Asta Medica AG
    Inventors: Michael Lobisch, Ralph Venhaus, Bernd Nickel, Istvan Szelenyi, Jurgen Engel, Peter Emig
  • Pharmaceutical composition comprising flupirtine and its use to combat muscular tension
    Patent number: 5162346
    Abstract: Flupirtine is used for the treatment of disorders involving skeletal muscle tension.
    Type: Grant
    Filed: July 10, 1991
    Date of Patent: November 10, 1992
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Michael Lobisch, Ralph Venhaus, Bernd Nickel, Istvan Szelenyi, Jurgen Engel, Peter Emig